255 related articles for article (PubMed ID: 6761010)
1. Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.
Calvert AH; Harland SJ; Newell DR; Siddik ZH; Jones AC; McElwain TJ; Raju S; Wiltshaw E; Smith IE; Baker JM; Peckham MJ; Harrap KR
Cancer Chemother Pharmacol; 1982; 9(3):140-7. PubMed ID: 6761010
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of carboplatin in small cell lung cancer.
Tamura T; Saijo N; Shinkai T; Eguchi K; Sasaki Y; Sakurai M; Fujiwara Y; Nakano H; Nakagawa K; Minato K
Jpn J Clin Oncol; 1988 Mar; 18(1):27-32. PubMed ID: 2832635
[TBL] [Abstract][Full Text] [Related]
3. A phase I trial of cis-diammine-1,1-cyclobutane dicarboxylate platinum II (Carboplatin, CBDCA, JM-8) with a single dose every five week-schedule.
Joss RA; Kaplan S; Goldhirsch A; Sessa C; Brunner KW; Cavalli F
Invest New Drugs; 1984; 2(3):297-304. PubMed ID: 6392147
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function.
Harland SJ; Newell DR; Siddik ZH; Chadwick R; Calvert AH; Harrap KR
Cancer Res; 1984 Apr; 44(4):1693-7. PubMed ID: 6367971
[TBL] [Abstract][Full Text] [Related]
5. Phase I clinical trial of the novel platin complex dicycloplatin: clinical and pharmacokinetic results.
Li S; Huang H; Liao H; Zhan J; Guo Y; Zou BY; Jiang WQ; Guan ZZ; Yang XQ
Int J Clin Pharmacol Ther; 2013 Feb; 51(2):96-105. PubMed ID: 23127487
[TBL] [Abstract][Full Text] [Related]
6. Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusion.
Koeller JM; Trump DL; Tutsch KD; Earhart RH; Davis TE; Tormey DC
Cancer; 1986 Jan; 57(2):222-5. PubMed ID: 3510700
[TBL] [Abstract][Full Text] [Related]
7. Platinum analogue combination chemotherapy: cisplatin and carboplatin--a phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carboplatin excretion.
Trump DL; Grem JL; Tutsch KD; Willson JK; Simon KJ; Alberti D; Storer B; Tormey DC
J Clin Oncol; 1987 Aug; 5(8):1281-9. PubMed ID: 3040920
[TBL] [Abstract][Full Text] [Related]
8. Blood clearance of radioactively labelled cis-diammine 1,1-cyclobutane dicarboxylate platinum (II) (CBDCA) in cancer patients.
Sharma H; Thatcher N; Baer J; Zaki A; Smith A; McAucliffe CA; Crowther D; Owens S; Fox BW
Cancer Chemother Pharmacol; 1983; 11(1):5-7. PubMed ID: 6349844
[TBL] [Abstract][Full Text] [Related]
9. Phase 1 study of carboplatin in patients with advanced cancer, intermittent intravenous bolus, and 24-hour infusion.
Leyvraz S; Ohnuma T; Lassus M; Holland JF
J Clin Oncol; 1985 Oct; 3(10):1385-92. PubMed ID: 3900302
[TBL] [Abstract][Full Text] [Related]
10. Phase I study of ethylenediamine platinum(II) malonate (NSC 146 068), a second generation platinum analogue.
Winograd B; Vermorken JB; ten Bokkel Huinink WW; Simonetti G; Gall HE; Knobf MK; van der Vijgh WJ; McVie JG; Pinedo HM
Cancer Res; 1986 Apr; 46(4 Pt 2):2148-51. PubMed ID: 3948186
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function.
Egorin MJ; Van Echo DA; Tipping SJ; Olman EA; Whitacre MY; Thompson BW; Aisner J
Cancer Res; 1984 Nov; 44(11):5432-8. PubMed ID: 6386150
[TBL] [Abstract][Full Text] [Related]
12. Prediction of hematologic toxicity of carboplatin by creatinine clearance rate.
Taguchi J; Saijo N; Miura K; Shinkai T; Eguchi K; Sasaki Y; Tamura T; Sakurai M; Minato K; Fujiwara Y
Jpn J Cancer Res; 1987 Sep; 78(9):977-82. PubMed ID: 3117753
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of carboplatin in non-small cell lung cancer.
Tamura T; Shinkai T; Eguchi K; Sasaki Y; Fujiwara Y; Fukuda M; Ohe Y; Nakagawa K; Minato K; Saijo N
Jpn J Clin Oncol; 1989 Mar; 19(1):51-5. PubMed ID: 2537907
[TBL] [Abstract][Full Text] [Related]
14. A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240).
Curt GA; Grygiel JJ; Corden BJ; Ozols RF; Weiss RB; Tell DT; Myers CE; Collins JM
Cancer Res; 1983 Sep; 43(9):4470-3. PubMed ID: 6347373
[TBL] [Abstract][Full Text] [Related]
15. Preliminary phase I clinical study and pharmacokinetics of (1,2-diaminocyclohexane) (isocitrato) platinum (II) or PHIC.
Gouyette A; Ducret JP; Caillé P; Amiel JL; Rouëssé J; Foka M; Carde P; Hayat M; Sancho-Garnier H
Anticancer Res; 1986; 6(5):1127-32. PubMed ID: 3800320
[TBL] [Abstract][Full Text] [Related]
16. [Phase I study of a new platinum complex 254-S, cis-diammine (glycolato)-platinum (II)].
Ota K; Wakui A; Majima H; Niitani H; Inuyama Y; Ogawa M; Ariyoshi Y; Yoshida O; Taguchi T; Kimura I
Gan To Kagaku Ryoho; 1992 Jun; 19(6):855-61. PubMed ID: 1605663
[TBL] [Abstract][Full Text] [Related]
17. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
18. Phase I studies with carboplatin at the Royal Marsden Hospital.
Calvert AH; Harland SJ; Newell DR; Siddik ZH; Harrap KR
Cancer Treat Rev; 1985 Sep; 12 Suppl A():51-7. PubMed ID: 3910222
[TBL] [Abstract][Full Text] [Related]
19. Combined carboplatin and cisplatin. Limited prospects for dose intensification.
Waterhouse DM; Reynolds RK; Natale RB
Cancer; 1993 Jun; 71(12):4060-6. PubMed ID: 8508371
[TBL] [Abstract][Full Text] [Related]
20. Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion.
Sasaki Y; Amano T; Morita M; Shinkai T; Eguchi K; Tamura T; Ohe Y; Kojima A; Saijo N
Cancer Res; 1991 Mar; 51(5):1472-7. PubMed ID: 1997185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
